UNICYCIVE THERAPEUTICS, INC. Other Nonoperating Income (Expense)
UNICYCIVE THERAPEUTICS, INC. (UNCY) reported Other Nonoperating Income (Expense) of -$11.76 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-13.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2024-05-13
- UNICYCIVE THERAPEUTICS, INC. other nonoperating income (expense) for the quarter ending 2024-03-31 was -$11.76M.
- UNICYCIVE THERAPEUTICS, INC. other nonoperating income (expense) for the quarter ending 2023-03-31 was -$10.37M.
- UNICYCIVE THERAPEUTICS, INC. other nonoperating income (expense) for fiscal 2023 was -$9.77M.
- UNICYCIVE THERAPEUTICS, INC. other nonoperating income (expense) for fiscal 2022 was -$6.00K.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 12 month |
|---|---|---|
| 2024-03-31 | -$11.76M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | -$9.77M 10-K · filed 2024-03-28 | |
| 2023-03-31 | -$10.37M 10-Q · filed 2024-05-13 | |
| 2022-12-31 | -$6.00K 10-K · filed 2024-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |